SCLX
Scilex Holding CoCompany Information
- Company Name
- Scilex Holding Co
- CIK
- CIK0001820190
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- SCLX: Nasdaq, SCLXW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- SCLX
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-12-18
- Last sale
- 2025-12-30
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 9,657,300
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 681,852
- Shares outstanding
- 6,892,000
- Ownership
- 9.89%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -19.90%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 3 | 5 | 1 | 4 | 6 | 3 | 0 | 7 | 2 | 4 | 2 | ||||||
| Marketable Securities | 0 | 0 | 6 | - | - | - | 0 | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 6 | 11 | 15 | 12 | 17 | 11 | 26 | 32 | 38 | 30 | 35 | 16 | ||||||
| Accounts And Other Receivables Net Current | 19 | 19 | - | - | - | - | - | - | - | - | - | - | ||||||
| Inventory Net | 4 | 5 | 5 | 1 | 3 | 3 | 2 | 2 | 3 | 3 | 4 | 4 | ||||||
| Other Prepaid Expense Current | 6 | 4 | 7 | 3 | 10 | 9 | 9 | 6 | 2 | 3 | 4 | 3 | ||||||
| Assets Current | 36 | 42 | 38 | 16 | 34 | 29 | 42 | 40 | 50 | 38 | 47 | 25 | ||||||
| Property Plant And Equipment Net | 13 | 13 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 14 | 14 | 15 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Intangible Assets Net Excluding Goodwill | 58 | 60 | 59 | 30 | 31 | 31 | 32 | 33 | 34 | 35 | 36 | 38 | ||||||
| Investments | 5 | 5 | 1 | 0 | 2 | 2 | 2 | 2 | - | - | 0 | - | ||||||
| Equity Method Investment Aggregate Cost | 57 | 79 | 127 | 16 | - | - | 0 | - | - | - | - | - | ||||||
| Goodwill | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | ||||||
| Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 8 | 3 | 1 | 1 | 0 | ||||||
| Assets | 254 | 294 | 365 | 276 | 84 | 79 | 93 | 100 | 105 | 91 | 101 | 81 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 121 | 102 | 86 | 67 | 59 | 57 | 53 | 43 | 42 | 42 | 41 | 33 | ||||||
| Accrued Salaries Current | 4 | 4 | 3 | 0 | 2 | 2 | 2 | 1 | 4 | 4 | 3 | 3 | ||||||
| Other Accrued Liabilities Current | 256 | 248 | 232 | 213 | 193 | 168 | 163 | 142 | 125 | 104 | 90 | 66 | ||||||
| Debt Current | 81 | 81 | 83 | 46 | 40 | 39 | 35 | 85 | 75 | 93 | 108 | 115 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Liabilities Current | 3 | 0 | 3 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 512 | 502 | 484 | 359 | 306 | 276 | 260 | 282 | 255 | 253 | 250 | 229 | ||||||
| Other Long Term Debt Noncurrent | 0 | 0 | 22 | 0 | 0 | 0 | 1 | 14 | 29 | 16 | 17 | 7 | ||||||
| Derivative Liabilities Noncurrent | 32 | 26 | 51 | 82 | 20 | 8 | 18 | 11 | 30 | 7 | 2 | 2 | ||||||
| Operating Lease Liability Noncurrent | 13 | 13 | 13 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 564 | 548 | 577 | 456 | 333 | 290 | 286 | 312 | 319 | 281 | 274 | 243 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 854 | 799 | 797 | 785 | 453 | 448 | 455 | 431 | 426 | 415 | 408 | 397 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -7 | -7 | -6 | 3 | 6 | 6 | 6 | 5 | 2 | - | 0 | - | ||||||
| Retained Earnings Accumulated Deficit | -1,079 | -965 | -922 | -889 | -631 | -589 | -563 | -557 | -552 | -515 | -490 | -469 | ||||||
| Treasury Stock Value | -77 | -77 | -77 | -77 | -77 | -77 | -91 | -91 | -91 | -91 | -91 | -91 | ||||||
| Stockholders Equity | -308 | -249 | -212 | -180 | -249 | -211 | -193 | -211 | -215 | -190 | -173 | -163 | ||||||
| Minority Interest | -2 | -5 | -4 | -3 | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 254 | 294 | 365 | 276 | 84 | 79 | 93 | 100 | 105 | 91 | 101 | 81 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | 29 | 29 | 29 | 29 | 29 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | 29 | 29 | 29 | 29 | 29 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | 740 | ||||||
| Common Stock Shares Issued | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 192 | 3 | 166 | 160 | 0 | ||||||
| Shares Outstanding | 7 | 8 | 7 | 6 | 5 | 5 | 5 | 132 | 121 | 106 | 100 | 94 | ||||||
| Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 60 | 60 | 60 | 60 | 60 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialScilex Holding Co (SCLX) — SEC Financial Statements & Analysis
Scilex Holding Co (SCLX) is a biological products, (no diagnostic substances) company, incorporated in DE. Scilex Holding Co trades on Nasdaq as: SCLX, SCLXW. Scilex Holding Co (SCLX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Scilex Holding Co carries a market cap of $53.76M, a P/E ratio of -0.11x, a P/B ratio of -0.17x, a P/S ratio of 1.70x, an enterprise value of $134.00M, and an EV/EBITDA multiple of -0.38x. On profitability, it posts a gross margin of 55.50%, an operating margin of -1136.40%, a net margin of -1559.72%, a Return on Equity (ROE) of 176.23%, and a Return on Assets (ROA) of -292.30%. Per share, it reports EPS of $-71.53, diluted EPS of $-71.53, free cash flow per share of $-5.28, and a dividend per share of $0.61. Over the trailing year, it posted revenue growth of -28.55% year-over-year, net income growth of 987.50% year-over-year, and EPS growth of 1729.59% year-over-year. On the balance sheet, it maintains a current ratio of 0.07x, a quick ratio of 0.06x, working capital of $-476.01M, a debt-to-equity ratio of -1.82x, a debt ratio of 2.22, an interest coverage ratio of -22.20x, free cash flow of $-36.38M (TTM), and net debt of $80.24M. Figures sourced from SEC EDGAR.
- Market Cap
- $53.76M
- P/E TTM
- -0.11x
- EPS TTM
- $-71.53
- P/B TTM
- -0.17x
- ROE TTM
- 176.23%
- ROA TTM
- -292.30%
- Debt To Equity
- -1.82x
- Free Cash Flow TTM
- $-36.38M
- Net Revenue TTM Growth 1Y
- -28.55%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Scilex Holding Co in?
Scilex Holding Co (SCLX) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does SCLX trade on?
Scilex Holding Co (SCLX) trades on the Nasdaq.
Where is Scilex Holding Co incorporated?
Scilex Holding Co is incorporated in DE.
When was Scilex Holding Co (SCLX)'s most recent SEC filing?
Scilex Holding Co (SCLX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is SCLX's market cap?
Scilex Holding Co (SCLX) has a market capitalization of $53.76M as of 2026-06-30.
What is SCLX's EPS (earnings per share)?
Scilex Holding Co (SCLX)'s trailing twelve month EPS is $-71.53 as of 2026-06-30.
What is SCLX's ROE (return on equity)?
Scilex Holding Co (SCLX)'s trailing twelve month Return on Equity (ROE) is 176.23% as of 2026-06-30.
What is SCLX's ROA (return on assets)?
Scilex Holding Co (SCLX)'s trailing twelve month Return on Assets (ROA) is -292.30% as of 2026-06-30.
What is SCLX's EV/EBITDA?
Scilex Holding Co (SCLX)'s trailing twelve month EV/EBITDA is -0.38x as of 2026-06-30.